Latest filing published 08 Sept 2026 for Cullinan Therapeutics, Inc., €152k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jennifer Michaelson on record concern Cullinan Therapeutics, Inc. Between 6 July 2026 and 8 September 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 8 September 2026, the filings show a transaction worth €152k in Cullinan Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations